NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcription-Reference-Cited by-同舟云学术

NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcription

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zao Xiaobin¹,Cheng Jin²,Shen Congle¹,Guan Guiwen¹,Feng Xiaoyu¹,Zou Jun¹,Zhang Jing¹,Liu Tianxu¹,Zheng Huiling¹,Zhang Ting¹,Wang Jie¹,Liu Jia¹,Li Deyao¹,Lu Fengmin¹³^ORCID,You Fuping⁴,Chen Xiangmei¹

Affiliation:

1. Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing, China

2. Department of Sports Medicine, Peking University Third Hospital, Institute of Sports Medicine of Peking University, Beijing Key Laboratory of Sports Injuries, Beijing, China

3. Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, China

4. Institute of Systems Biomedicine, Department of Immunology, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China

Funder

Beijing Natural Science Foundation

Natural Science Foundation of China

National S & T Major Project for Infectious Diseases of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1869388

Reference50 articles.

1. Hepatocellular Carcinoma and Hepatitis B Virus